Dr. Thomas Pedicino Kole, MD, PhD

  • New York, NY
  • Radiation oncologist
NPI1598064545PAC ID4789995556
Medicare services, 2024
2,278
Medicare patients, 2024
293
Part D claims, 2024
545
Publications
21
Clinical trials
2
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 10 affiliations

Find Dr. Kole's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Thomas Pedicino Kole is a radiation oncologist in New York, New York

Dr. Kole practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Kole's NPI, 1598064545, was assigned on March 16, 2011. Dr. Kole graduated from Rutgers New Jersey Medical School in 2010. Dr. Kole holds New Jersey license 25MA09778100.

NPI and contact details
Medicare PAC ID
4789995556
NPI enumeration date
March 16, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
42
Medical school graduation
2010

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Thomas Pedicino Kole practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Kole's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Thomas Pedicino Kole is affiliated with 5 sites of care and 5 medical groups

Dr. Kole's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Valley Medical Group. Dmand AI also links Dr. Kole to 4 more group practices and clinics and 4 medical groups, each named with a free account.

See all 10 affiliations for Dr. Kole

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Thomas Pedicino Kole's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kole practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+4 more sites and 4 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Kole practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Thomas Pedicino Kole is one of 385 radiation oncologists in New York

Radiation oncology is Dr. Kole's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kole is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kole's licenses on file in 4 states: New Jersey, Florida, New York and District of Columbia.

Specialties and state licenses

  • Radiation oncology, New JerseyPrimaryLicense 25MA09778100 · 2015 to 2027 · taxonomy 2085R0001X
  • Florida licenseSince 2025
  • New York license2015 to 2026
  • District of Columbia license2011 to 2012

Clinical focus

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Kole treats.

Radiation oncologists near Dr. Kole

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Thomas Pedicino Kole billed Medicare for 2,278 services in 2024

CMS data shows 2,278 Medicare services from Dr. Kole across 19 procedure codes in 2024, for 293 Medicare patients. Medicare paid $228,016 for them.

Medicare services, 20242,278
Medicare patients293
Paid by Medicare$228,016
Procedure codes19

Dr. Kole's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 2,0672024: 1,73416%
Other services
2023: 1122024: 22298%
Office and hospital visits
2023: 2512024: 18227%
Surgery
2023: 1252024: 14012%

Where Dr. Kole's Medicare services took place, 2024

  • In an office62728%
  • In a facility1,65172%

Dr. Kole compared with the New York median for radiation oncologists, 2024

  • Dr. Kole
  • New York median
Medicare services
2,278vs 1,0542.2 times
Medicare patients
293vs 16083% above
Part D claims
468vs 3613.0 times

Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.

Dr. Kole's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kole

Need commercial claims for Dr. Kole?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kole and other radiation oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Thomas Pedicino Kole treated 293 Medicare patients in 2024, average age 75

CMS counts 293 Medicare patients who saw Dr. Kole in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kole's median patient age at 72, with 7% women.

Medicare patients, 2024293
Average age75
Average risk score1.35
Also on Medicaid4%

Dr. Kole's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Kole's Medicare patients by sex, 2024

  • Women9031%
  • Men20369%

Chronic conditions among Dr. Kole's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Arthritis43%
  5. Ischemic heart disease35%
  6. Diabetes29%
  7. Anxiety28%
  8. Chronic kidney disease20%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kole's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women7%
  • Men92%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Thomas Pedicino Kole wrote 545 Medicare Part D claims in 2024

In 2024, Dr. Kole wrote 545 Medicare Part D claims for 166 patients. 97% of them were for generic drugs. CMS names the drug for 468 of them, across 4 drugs with 11 or more claims each, at $5,257 in total drug cost. In 2023, CMS named 449 claims across 3 drugs.

Part D claims, 2024545
Drugs named by CMS4
Total drug cost$5,257
Part D patients166

Dr. Kole's Part D claims by kind of drug, 2024

  • Generic529 claims97%
  • Brand-name16 claims3%

Dr. Kole's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kole's Part D claims, 2024

  • Antibiotics14%77 of 545 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4492024: 4684%

Drugs named by CMS: 4 in 2024, 3 in 2023.

See all prescribing by Dr. Kole

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Thomas Pedicino Kole scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kole for performance year 2024, reported through an alternative payment model (APM). Dr. Kole accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kole as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Kole's MIPS scores, performance year 2024

  • 95of 100Final score
  • 85.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Kole by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Thomas Pedicino Kole has 21 publications on record

Dmand AI links 21 papers to Dr. Kole, published from 2013 to 2023. 2015 was the busiest year, with 5. The most frequent topics are Radiosurgery, Prostatic Neoplasms and Urinary Bladder. Dr. Kole has published most often in Acta Oncol. Dr. Kole's most frequent co-authors are Brian Collins, John Hugh Lynch, MD and Olusola Obayomi-Davies, MD.

Papers21
Years published2013 to 2023

Dr. Kole's papers by year, 2013 to 2023

Topics Dr. Kole writes about most

  • Radiosurgery
  • Prostatic Neoplasms
  • Urinary Bladder
  • Organs at Risk
  • Organ Size
  • Rectum

Dr. Kole's most frequent co-authors

Recent publications by Dr. Kole

See all 21 publications and co-authors

See who Dr. Kole researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kole works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Thomas Pedicino Kole has worked on 2 clinical trials

Dmand AI links Dr. Kole to 2 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. NRG Oncology sponsors the most, 2.

Conditions in Dr. Kole's trials

  • Prostatic Neoplasms
  • Prostatic Diseases

Investigators on the most trials with Dr. Kole

Recent clinical trials with Dr. Kole

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Thomas Pedicino Kole received $9,088 in industry payments from 2016 to 2025

CMS Open Payments shows 94 general payments to Dr. Kole from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Brainlab, Inc. paid the most, $4,773.

General payments to Dr. Kole by program year, 2016 to 2025

General payments to Dr. Kole by kind, 2016 to 2025

$9.1Kin total
  • Food and beverage$4,26447%
  • Travel and lodging$2,32426%
  • Consulting fees$1,50017%
  • Honoraria$1,00011%

Companies that paid Dr. Kole the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kole

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Thomas Pedicino Kole has 2 awards and honors on record

Dmand AI lists 2 awards for Dr. Kole, most recently Stanley Bergen Medal of Excellence in 2010.

Awards and honors for Dr. Kole

  1. 2010
    • Stanley Bergen Medal of Excellence
  2. 2009
    • Member

Source: Dmand AI Professional Profile Data

Dr. Thomas Pedicino Kole graduated from Rutgers New Jersey Medical School

Dr. Kole graduated from Rutgers New Jersey Medical School in 2010. Dr. Kole is a member of AOA and ASTRO.

  1. Medical schoolRutgers New Jersey Medical School
  2. Board certified in radiation oncologyAmerican Board of Radiology

Source: Dmand AI Professional Profile Data

Dr. Thomas Pedicino Kole accepts plans from 15 insurance carriers

Dr. Kole is in network with 15 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.

  • Elevance
  • Aetna
  • United Healthcare
  • HCSC
  • Horizon Blue Cross Blue Shield of New Jersey
  • Aspirus Health Plan
  • Blue Cross Blue Shield of Massachusetts
  • Blue Cross Blue Shield of Michigan
  • +7 more carriersWith a free account

Plan types Dr. Kole accepts, by number of carriers

  1. Medicare11
  2. PPO11
  3. HMO6
  4. EPO4
  5. POS4
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Thomas Pedicino Kole's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Thomas Pedicino Kole

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Thomas Pedicino Kole's NPI number?

Dr. Thomas Pedicino Kole's NPI number is 1598064545. It was assigned on March 16, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Thomas Pedicino Kole?

Dr. Thomas Pedicino Kole is a radiation oncologist in New York, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Thomas Pedicino Kole practice?

Dr. Kole practices at 1275 York Avenue, New York, NY 10065. Dr. Kole's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Kole to 4 group practices and clinics and 4 medical groups.

What is Dr. Thomas Pedicino Kole's medical license number?

Dr. Kole holds New Jersey license 25MA09778100, one of the licenses on file in 4 states.

Which states has Dr. Thomas Pedicino Kole been licensed in?

Dmand AI has state licenses on file for Dr. Kole in New Jersey (2015 to 2027), Florida (since 2025), New York (2015 to 2026) and District of Columbia (2011 to 2012).

Which hospitals is Dr. Thomas Pedicino Kole affiliated with?

Dr. Kole practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Thomas Pedicino Kole part of?

Dr. Kole is linked to Valley Medical Group. Dmand AI links Dr. Kole to 4 more medical groups.

Does Dr. Thomas Pedicino Kole accept Medicare?

Yes. CMS data shows Dr. Kole billed Medicare for 2,278 services in 2024, and Dr. Kole accepts Medicare assignment.

Does Dr. Thomas Pedicino Kole offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Kole as offering telehealth services.

What is Dr. Thomas Pedicino Kole's MIPS score?

Dr. Kole's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Thomas Pedicino Kole see?

CMS counts 293 Medicare patients who saw Dr. Kole in 2024, with an average age of 75.

Is Dr. Thomas Pedicino Kole board certified?

Yes. Dr. Kole is board certified in radiation oncology by the American Board of Radiology.

What services does Dr. Thomas Pedicino Kole bill to Medicare?

In 2024, Dr. Kole's most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and radiation oncology (77427).

Where did Dr. Thomas Pedicino Kole go to medical school?

Dr. Kole graduated from Rutgers New Jersey Medical School in 2010.

What drugs does Dr. Thomas Pedicino Kole prescribe most?

In 2024 Medicare Part D data, Dr. Kole's most prescribed drugs by claims were Tamsulosin HCl, Dexamethasone and Sulfamethoxazole-Trimethoprim.

Has Dr. Thomas Pedicino Kole received payments from drug or device companies?

CMS Open Payments shows $9,088 in general payments to Dr. Kole from 24 companies from 2016 to 2025. The largest total came from Brainlab, Inc.

How long has Dr. Thomas Pedicino Kole been practicing?

Dr. Kole graduated from medical school in 2010, 16 years ago.

Does Dr. Thomas Pedicino Kole do research?

Dmand AI links 21 publications to Dr. Kole, published from 2013 to 2023. Dr. Kole has worked on 2 clinical trials.

Who does Dr. Thomas Pedicino Kole publish with?

Dr. Kole's most frequent co-authors are Brian Collins (5 shared papers), John Hugh Lynch, MD (4 shared papers) and Olusola Obayomi-Davies, MD (4 shared papers).

What insurance does Dr. Thomas Pedicino Kole accept?

Dr. Kole is in network with 15 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to radiation oncology practices?

See radiation oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)